ALS Ltd (ASX: ALQ) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

ALS Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $10.97 billion
P/E Ratio 34.30
Dividend Yield 1.97%
Shares Outstanding 507.54 million
Earnings per share 0.630
Dividend per share 0.43
Year To Date Return -0.90%
Earnings Yield 2.92%
Franking 30
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • ALS Ltd (ASX: ALQ)
    Latest News

    An investor looks happy holding a finger to his computer screen while holding a coffee cup in a home office scenario.
    Industrials Shares

    ALS FY26 results: Record growth, leadership moves, digital push

    ALS posts record FY26 results with standout Minerals growth and advances in digital transformation.

    Read more »

    Doctor sees virtual images of the patient's x-rays on a blue background.
    ASX Share Market News

    Why might Pro Medicus shares soon be under pressure?

    The winners and losers from index rebalances have been named.

    Read more »

    A man closely watches a clock.
    Dividend Investing

    15 ASX shares going ex-dividend before EOFY

    Champion Iron, Select Harvests, and Tower are among the ASX shares with ex-dividend dates in June.

    Read more »

    Five young people sit in a row having fun and interacting with their mobile phones.
    Share Gainers

    4 ASX 200 stocks rocketing higher this week

    Investors sent these four ASX 200 shares flying higher this week. But why?

    Read more »

    A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
    Broker Notes

    3 ASX shares Morgans rates as buys this week

    Let's see what the broker is recommending to clients.

    Read more »

    Girl with painted hands.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    Investors were back to the races this Tuesday.

    Read more »

    A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
    Broker Notes

    Buy, hold, sell: Endeavour and these popular ASX shares

    Let's see what analysts have to say about these shares this week.

    Read more »

    Excited couple celebrating success while looking at smartphone.
    Broker Notes

    Buy this ASX 200 stock for a 21% return: Broker

    Big returns could be on the cards for buyers of this stock according to Bell Potter.

    Read more »

    Happy construction worker at a building site with a group of workers in the background.
    Industrials Shares

    Why is this ASX industrials stock edging higher today?

    The company reported strong profit, dividend, and revenue growth.

    Read more »

    Man raising both his arms in the air with a piggy bank on his lap, symbolising a record high.
    Industrials Shares

    ALS reports record FY26 earnings and dividend uplift

    ALS Ltd reported 10.7% revenue growth, a 25.8% rise in NPAT, stronger margins, and a higher dividend.

    Read more »

    Happy construction worker at a building site with a group of workers in the background.
    ASX Share Market News

    Why investors should buy the dip on this ASX industrials stock

    Is now the time to buy this stock?

    Read more »

    Cybersecurity professional man inspects server room and works on iPad.
    Healthcare Shares

    ALS reports cyber security incident impacting operations

    ALS discloses a cyber security breach affecting operations; most systems are restored as investigations continue.

    Read more »

    Frequently Asked Questions

    Yes, ALS Ltd historically pays two partially or fully franked dividends a year.

    ALS Ltd generally pays its shareholder dividends in July and December

    ALS Ltd listed on the ASX on 18 July 1952.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    12 Jun 2026 $0.2310 30.00% Final 03 Jul 2026
    26 Nov 2025 $0.1940 29.90% Interim 17 Dec 2025
    03 Jul 2025 $0.1970 30.00% Final 25 Jul 2025
    27 Nov 2024 $0.1890 30.00% Interim 19 Dec 2024
    12 Jun 2024 $0.1960 20.00% Final 02 Jul 2024
    23 Nov 2023 $0.1960 20.00% Interim 14 Dec 2023
    09 Jun 2023 $0.1940 10.00% Final 06 Jul 2023
    24 Nov 2022 $0.2030 0.00% Interim 16 Dec 2022
    06 Jun 2022 $0.1700 30.00% Final 04 Jul 2022
    02 Dec 2021 $0.1580 30.00% Interim 17 Dec 2021
    07 Jun 2021 $0.1460 70.00% Final 05 Jul 2021
    26 Nov 2020 $0.0850 100.00% Interim 16 Dec 2020
    05 Jun 2020 $0.0610 70.00% Final 06 Jul 2020
    27 Nov 2019 $0.1150 30.00% Interim 16 Dec 2019
    03 Jun 2019 $0.1150 35.04% Final 01 Jul 2019
    29 Nov 2018 $0.1100 20.00% Interim 18 Dec 2018
    06 Jun 2018 $0.0900 40.00% Final 02 Jul 2018
    29 Nov 2017 $0.0800 40.00% Interim 18 Dec 2017
    07 Jun 2017 $0.0000 0.00% Final 03 Jul 2017
    05 Dec 2016 $0.0550 60.00% Interim 21 Dec 2016
    08 Jun 2016 $0.0600 40.00% Final 01 Jul 2016
    03 Dec 2015 $0.0750 25.07% Interim 18 Dec 2015
    11 Jun 2014 $0.2000 50.00% Final 02 Jul 2014
    07 Jun 2013 $0.2700 50.00% Final 02 Jul 2013
    05 Jun 2009 $0.4250 0.00% Final 01 Jul 2009
    01 Dec 2008 $0.4250 58.82% Interim 17 Dec 2008
    06 Jun 2008 $0.5100 58.82% Final 01 Jul 2008
    30 Nov 2007 $0.2975 58.82% Interim 17 Dec 2007
    06 Jun 2007 $0.3570 58.82% Final 02 Jul 2007
    29 Nov 2006 $0.2380 58.82% Interim 15 Dec 2006
    05 Jun 2006 $0.2900 100.00% Final 03 Jul 2006
    25 Nov 2005 $0.2100 100.00% Interim 20 Dec 2005
    04 Jun 2004 $0.1900 100.00% Final 01 Jul 2004
    28 Nov 2003 $0.1400 100.00% Interim 19 Dec 2003

    ALQ ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About ALS Ltd

    ALS Ltd (ASX: ALQ) is one of the world's largest laboratory testing, inspection, certification, and verification businesses. It operates from around 350 sites across 65 countries.

    Listed on the ASX in 1952, ALS operates two reportable divisions: Commodities and Life Sciences. ALS's Commodities segment traditionally generates the majority of the company's underlying earnings. It provides geochemistry, metallurgy, inspection, and mine site services for the mining industry globally.

    The company also provides environmental, pharmaceutical, and food and beverage testing and certification through its Life Sciences division. ALS Ltd has a multi-billion dollar market capitalisation and is part of the ASX 100.

    ALQ Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    31 Jul 2026 $21.61 $0.20 0.93% 1,327,387 $21.45 $21.78 $21.29
    30 Jul 2026 $21.41 $0.17 0.80% 2,030,723 $21.21 $21.77 $20.94
    29 Jul 2026 $21.24 $-0.58 -2.66% 2,962,106 $22.00 $22.00 $21.11
    28 Jul 2026 $21.82 $0.56 2.63% 2,399,370 $22.16 $22.75 $21.50
    27 Jul 2026 $21.26 $0.80 3.91% 2,205,563 $20.84 $21.39 $20.64
    24 Jul 2026 $20.46 $-1.68 -7.59% 2,632,177 $21.98 $22.03 $20.46
    23 Jul 2026 $22.14 $-0.19 -0.85% 1,617,704 $22.46 $22.83 $22.07
    22 Jul 2026 $22.33 $0.31 1.41% 988,665 $21.93 $22.45 $21.76
    21 Jul 2026 $22.02 $0.22 1.01% 847,134 $21.76 $22.13 $21.52
    20 Jul 2026 $21.80 $-0.16 -0.73% 1,093,119 $21.95 $22.13 $21.58
    17 Jul 2026 $21.96 $0.04 0.18% 840,685 $21.95 $21.97 $21.61
    16 Jul 2026 $21.92 $-0.32 -1.44% 1,347,584 $22.06 $22.21 $21.37
    15 Jul 2026 $22.24 $0.13 0.59% 607,914 $22.25 $22.39 $22.14
    14 Jul 2026 $22.11 $-0.21 -0.94% 843,389 $22.18 $22.28 $21.75
    13 Jul 2026 $22.32 $-0.22 -0.98% 1,048,352 $22.24 $22.61 $22.15
    10 Jul 2026 $22.54 $0.30 1.35% 882,159 $22.55 $22.77 $22.09
    09 Jul 2026 $22.24 $-0.23 -1.02% 964,556 $22.35 $22.48 $22.05
    08 Jul 2026 $22.47 $-0.68 -2.94% 1,272,464 $22.96 $22.96 $22.13
    07 Jul 2026 $23.15 $-0.16 -0.69% 1,689,986 $23.29 $23.59 $22.87
    06 Jul 2026 $23.31 $-0.11 -0.47% 950,152 $23.18 $23.63 $23.14
    03 Jul 2026 $23.42 $0.57 2.49% 1,133,846 $23.10 $23.42 $22.71
    02 Jul 2026 $22.85 $-0.18 -0.78% 2,667,728 $23.02 $23.13 $22.78

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    01 Jul 2026 Malcom Deane Expiry 49,181 $1,132,638
    As advised by the company. 468,509 rights, rights lapsed
    01 Jul 2026 Malcom Deane Exercise 145,177 $3,343,426
    Conversion of securities. 351,215 rights
    01 Jul 2026 Malcom Deane Issued 27,883 $642,145
    Issue of securities. 496,392 rights, per announcement
    01 Jul 2026 Malcom Deane Buy 145,177 $3,343,426
    Conversion of securities.
    29 May 2026 Catharine Farrow Buy 4,200 $100,425
    On-market trade.
    27 May 2026 Leslie Desjardins Buy 1,200 $28,300
    On-market trade.
    02 Dec 2025 Malcom Deane Sell 7,356 $161,317
    On-market trade. As per annouuncement on 05-12-2025
    26 Aug 2025 Siddhartha Kadia Buy 4,910 $59,236
    On-market trade. US$
    14 Aug 2025 Nigel Garrard Buy 1,328 $24,966
    On-market trade.
    07 Aug 2025 Erica Mann Buy 5,930 $108,044
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Nigel David Garrard Non-Executive DirectorNon-Executive Chairman Jun 2023
    Mr Garrard is an executive with a track record across the fast-moving consumer goods and industrial/manufacturing sectors. He has over 20 years' experience as an ASX-listed CEO across three companies. In 2019, he retired as Managing Director and CEO of Orora Limited. He led the demerger of Orora Limited from Amcor, and the subsequent listing of Orora Limited on ASX in 2013. He was President of the Amcor Australasia and Packaging Distribution business group, Managing Director of Coca-Cola Amatil's Food and Services Division, and Managing Director of SPC Ardmona. Nigel brings international experience across listed, not-for-profit, government and private entities. He is currently the Chairman of Ansell Limited, Chairman of Flinders Port Holdings Pty Ltd, Chairman of the McMahon Services advisory board, and Director of Treasury Wine Estates Limited.
    Ms Christina (Christy) Boyce Non-Executive Director Sep 2025
    Ms Boyce has over 25 years' advisory experience in Australia and the United States, advising senior leadership across a range of industries including consumer and industrial goods, agribusiness and resources. Christy was a director (senior partner) of Port Jackson Partners. Prior to this, she was a partner at McKinsey & Co, working in the firm's Sydney, New York and Chicago offices. Throughout her career, Christy has worked with a range of growth companies focusing on strategy, organisational effectiveness and sales and marketing. Christy is currently a non-executive director of JB Hifi, BAI Communications Australia, EMM Consulting and a non-executive director of The Hunger Project Australia. She is a member of the Risk Committee, People Committee.
    Ms Leslie A Desjardins Non-Executive Director Nov 2019
    Ms Desjardins has a background as a CFO and senior financial and governance professional in a range of multinational and global businesses. She has commercial and financial governance experience with multinational public companies in North America, Canada, and Australia each with global operations. Her areas of experience include CFO level executive and financial strategic leadership, M&A, corporate finance and treasury, governance, financial and tax compliance, and enterprise risk management. Leslie is currently a Director and Audit Committee member with Ansell Limited. During her executive career, Leslie served as Executive VP and CFO at Amcor Limited, a global leader in packaging of food, beverage, pharmaceutical and tobacco products. Prior to Amcor Ltd, Leslie served in financial and corporate strategic positions with General Motors Corporation, including Chief Financial Officer GM Holden Australia, Controller GM North America, Executive Director Manufacturing Finance and Director GM North America Strategy and Planning. She is the Chair of the Risk Committee, and a member of the People Committee.
    Dr Siddhartha Kadia Non-Executive Director Jan 2019
    Dr Kadia has lived and worked in the US, Japan, China, and India and has more than 25 years of international experience as a company director, executive and technical leader in the Life Sciences and TIC (testing, inspection and certification) sectors. Currently Siddhartha is CEO of Mesa Laboratories which commenced in April 2026. Siddhartha was formerly CEO and Director at Calibre Scientific, a privately held company that services life sciences tools industry and CEO of PhenomeX (Berkeley lights). In addition, he was President and CEO of EAG Laboratories, a global scientific testing company headquartered in San Diego, California. Prior to EAG, Siddhartha served as President of the Life Sciences Division at Life Technologies Corporation (NSDQ: LIFE), a publicly traded life sciences tools company. Siddhartha was also a management consultant at McKinsey & Company where his work focused on life sciences and healthcare related engagements. He is the Chair and a member of the Sustainability & Innovation Committee, and a member of the People Committee.
    Ms Erica Mann Non-Executive Director Mar 2024
    Ms Mann is a C-suite executive with a 30-year career across regulated, multi-channel and multi product environment in top DAX, NYSE, NASDAQ pharmaceutical, OTC and FMCG multinationals. Before retiring as an executive, Erica led Bayer's Consumer Health Division, one of the OTC companies. Prior to joining Bayer, she was President and General Manager of Pfizer Nutrition following its acquisition of Wyeth Inc, where she served as Senior Vice President of Global Nutrition. This followed other senior executive roles of other Fortune 500 companies including Eli Lily and Johnson & Johnson. She has held leadership positions in South Africa, Australia, New Zealand, Germany, Switzerland and the US. In addition to her executive experience in the nutrition and health industry, Erica has experience with global and emerging markets across Africa, China, Russia, and Brazil. Erica currently serves as an independent director of Kenvue and DSM-Firmenich. Erica was educated in South Africa and obtained diplomas in analytical chemistry (Tswane University, Pretoria), marketing management (IMM, Johannesburg), and small business development (SBDC -Johannesburg). She is a member of the Sustainability & Innovation Committee.
    Mr Peter Possemiers Non-Executive Director Nov 2022
    Mr Possemiers has a background as a TIC sector expert with almost 40 years' experience working as a senior executive in leadership roles globally for SGS. He has lead teams both regionally and globally most notably SGS's global Environment Health and Safety business, then a CHF 550 million business with a global headcount which exceeded 6000. As Executive Vice President, he was a member of the SGS Operations Council with responsibility for the strategic growth and profitability of the business, leading 15 strategic acquisitions. He is the Chair of the People Committee, and a member of the Risk Committee.
    Mr Malcom Deane Chief Strategy Officer General Manager Life Sciences - Food & Pharma Americas GeneralChief Executive OfficerManaging Director Mar 2023
    Mr Deane has served the company in leadership positions for the past 10 years in such roles as General Manager for Life Sciences Latin America, Food & Pharma Americas, and most recently as the Chief Strategy Officer, leading corporate strategy, business development and acquisitions.
    Ms Catharine Farrow Non-Executive Director Mar 2025
    Dr Farrow has more than 30 years of mining industry experience in all aspects of exploration, development, technical services, acquisitions, company building, operations, board governance and innovation/technology. Her experience ranges from the High Arctic to equatorial environments in base, critical and precious metals. Catharine also serves as a director of Franco-Nevada Corporation and is lead director of Aclara Resources Inc. She is a Member of the Board of Governors of Laurentian University. She is also in the mining and technology industries in both public and private companies, and academia as President of FarExGeoMine Ltd., where she provides advisory support in technical, governance, innovation and technology, organisational structure and as a witness. Catharine's executive career includes the role of Founding CEO and member of the Board of Directors of TMAC Resources Inc a public mining company based in Toronto. Previously she had been COO of KGHM International and held other executive roles in precursor companies from 2003 to 2012 including as Chief Technology Officer and Senior Vice President Corporate Development and Technical Services (including joint ventures, M&A opportunities, and strategy). She is a member of the Sustainability & Innovation Committee.
    Ms Dayna Field Company SecretaryGeneral Counsel Oct 2024
    -
    Stuart Hutton Chief Financial Officer
    -
    Dayna Field Company SecretaryGeneral Counsel
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 161,719,043 31.86%
    J P Morgan Nominees Australia Pty Limited 82,964,814 16.35%
    Citicorp Nominees Pty Limited 82,631,353 16.28%
    BNP Paribas Noms Pty Ltd. 23,719,300 4.67%
    Citicorp Nominees Pty Limited <Colonial First State Inv A/C> 8,518,977 1.68%
    Faircase Pty Ltd. 8,452,085 1.67%
    BNP Paribas Nominees Pty Ltd <Agency Lending A/C> 5,836,951 1.15%
    Australian Foundation Investment Company Limited 5,540,000 1.09%
    Argo Investments Limited 5,050,000 1.00%
    BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 4,419,932 0.87%
    HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 4,175,914 0.82%
    WHSP Holdings Pty Limited 3,303,306 0.65%
    Buttonwood Nominees Pty Ltd 2,600,000 0.51%
    Netwealth Investments Limited <Wrap Services A/C> 2,274,650 0.45%
    Ms Maryon Catherine Campbell <The Checkmate A/C> 1,836,273 0.36%
    UBS Nominees Pty Ltd. 1,177,483 0.23%
    Mutual Trust Pty Ltd 1,128,569 0.22%
    BNP Paribas Noms (NZ) Ltd. 1,123,820 0.22%
    Certane CT Pty Ltd <ALS LTI A/C> 1,080,489 0.21%
    Merrill Lynch (Australia) Nominees Pty Ltd 1,058,225 0.21%

    Profile

    since

    Note